Search
site map
IP Handbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
About
MIHR
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
BROOKE, Steve
Steve Brooke, an advisor for commercialization and corporate partnerships in PATH’s Technology Solutions Strategic Program, plays a lead role in public-private product development collaboration, product commercialization strategy, and intellectual property management. Mr. Brooke conceptualizes, develops, negotiates, and implements complex collaborations and strategies, and negotiates co-development, licensing issues, and agreements. He also provides guidance and advice to staff working in these areas and manages projects that have a high degree of commercialization and/or private partner focus. Prior to receiving a master of business administration degree in marketing and finance from Northwestern University, he served as marketing manager for a medical products company. Mr. Brooke has lived in both Europe and Asia.
Abstract
How Public–Private Partnerships Handle Intellectual Property: The PATH Experience
Abstract:
PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public and private sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH’s work improves global health and well-being. Over the past 28 years, PATH has demonstrated that public–private partnerships (PPPs) can effectively address unmet public health needs, particularly when managed with a clear understanding of both public and private sector objectives. Indeed, collaboration between public sector and private sector partners is an especially valuable way to develop and advance appropriate health technologies for use in developing countries. When developing and managing PPPs, PATH recognizes that intellectual property (IP) is an especially important component in the range of variables that affect the economic, technical, and programmatic feasibility of a new health technology intervention. Our goal, therefore, is to incorporate IP considerations as a fundamental part of the PPP process. We seek to manage IP strategically to avoid or quickly overcome any IP-related roadblocks. Using three case studies, this chapter illustrates PATH’s strategies for private sector collaboration, as well as PATH’s approaches to managing IP.
|